These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1775 related articles for article (PubMed ID: 16518375)

  • 1. Targeting multidrug resistance in cancer.
    Szakács G; Paterson JK; Ludwig JA; Booth-Genthe C; Gottesman MM
    Nat Rev Drug Discov; 2006 Mar; 5(3):219-34. PubMed ID: 16518375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse ATP-Binding Cassette (ABC) Transporters Conferring Multi-Drug Resistance.
    Li S; Zhang W; Yin X; Xing S; Xie HQ; Cao Z; Zhao B
    Anticancer Agents Med Chem; 2015; 15(4):423-32. PubMed ID: 25929575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABC Transporters in the Development of Multidrug Resistance in Cancer Therapy.
    Dlugosz A; Janecka A
    Curr Pharm Des; 2016; 22(30):4705-4716. PubMed ID: 26932159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relevance of multidrug resistance in the age of targeted therapy.
    Türk D; Szakács G
    Curr Opin Drug Discov Devel; 2009 Mar; 12(2):246-52. PubMed ID: 19333870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emergence of drug transporter-mediated multidrug resistance to cancer chemotherapy.
    Wu CP; Hsieh CH; Wu YS
    Mol Pharm; 2011 Dec; 8(6):1996-2011. PubMed ID: 21770407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer.
    Modok S; Mellor HR; Callaghan R
    Curr Opin Pharmacol; 2006 Aug; 6(4):350-4. PubMed ID: 16690355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATP binding cassette transporters and cancer: revisiting their controversial role.
    Sharma P; Singh N; Sharma S
    Pharmacogenomics; 2021 Dec; 22(18):1211-1235. PubMed ID: 34783261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade.
    Kathawala RJ; Gupta P; Ashby CR; Chen ZS
    Drug Resist Updat; 2015 Jan; 18():1-17. PubMed ID: 25554624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidrug efflux pumps and cancer stem cells: insights into multidrug resistance and therapeutic development.
    Moitra K; Lou H; Dean M
    Clin Pharmacol Ther; 2011 Apr; 89(4):491-502. PubMed ID: 21368752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies.
    Li W; Zhang H; Assaraf YG; Zhao K; Xu X; Xie J; Yang DH; Chen ZS
    Drug Resist Updat; 2016 Jul; 27():14-29. PubMed ID: 27449595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of bacterial efflux pumps that also inhibit efflux pumps of cancer cells.
    Amaral L; Spengler G; Martins A; Armada A; Handzlik J; Kiec-Kononowicz K; Molnar J
    Anticancer Res; 2012 Jul; 32(7):2947-57. PubMed ID: 22753759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tackling multidrug resistance mediated by efflux transporters in tumor-initiating cells.
    McIntosh K; Balch C; Tiwari AK
    Expert Opin Drug Metab Toxicol; 2016 Jun; 12(6):633-44. PubMed ID: 27116192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade.
    Chen Z; Shi T; Zhang L; Zhu P; Deng M; Huang C; Hu T; Jiang L; Li J
    Cancer Lett; 2016 Jan; 370(1):153-64. PubMed ID: 26499806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Advances in the targeting ATP-binding cassette transporters to overcome tumor multi-drug resistance].
    Wei N; Sun H; Liu GT
    Yao Xue Xue Bao; 2010 Oct; 45(10):1205-11. PubMed ID: 21348297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ascites Increases Expression/Function of Multidrug Resistance Proteins in Ovarian Cancer Cells.
    Mo L; Pospichalova V; Huang Z; Murphy SK; Payne S; Wang F; Kennedy M; Cianciolo GJ; Bryja V; Pizzo SV; Bachelder RE
    PLoS One; 2015; 10(7):e0131579. PubMed ID: 26148191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review. Comparison of multidrug resistant efflux pumps of cancer and bacterial cells with respect to the same inhibitory agents.
    Amaral L; Engi H; Viveiros M; Molnar J
    In Vivo; 2007; 21(2):237-44. PubMed ID: 17436571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABC transporters as mediators of drug resistance and contributors to cancer cell biology.
    Fletcher JI; Williams RT; Henderson MJ; Norris MD; Haber M
    Drug Resist Updat; 2016 May; 26():1-9. PubMed ID: 27180306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABC transporter superfamily. An updated overview, relevance in cancer multidrug resistance and perspectives with personalized medicine.
    Juan-Carlos PM; Perla-Lidia PP; Stephanie-Talia MM; Mónica-Griselda AM; Luz-María TE
    Mol Biol Rep; 2021 Feb; 48(2):1883-1901. PubMed ID: 33616835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance.
    Shi Z; Peng XX; Kim IW; Shukla S; Si QS; Robey RW; Bates SE; Shen T; Ashby CR; Fu LW; Ambudkar SV; Chen ZS
    Cancer Res; 2007 Nov; 67(22):11012-20. PubMed ID: 18006847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multidrug resistance of cancer cells mediated by ABC superfamily transporters].
    Ueda K
    Nihon Rinsho; 1997 May; 55(5):1024-9. PubMed ID: 9155147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 89.